Adoption of technology in the healthcare field has been happening at an incredibly slow pace. This is a fact that new would disagree with. The market is saturated with health tech companies that are vying to be the next big unicorn in the field, but long sales cycles and simple underestimations of what is needed for HIPAA and FDA approval has led to the demise of many of these projects. The ones that do receive enough series funding to produce finessed products for health systems and pharmaceutical companies however soon realize that the battle against time is not over.
Simply getting into a health system is not enough. Once a contract is finally ironed out and software is exchanged, the next uphill battle against the slow-pace of internal adoption is mounted.Read More